ZhongAn seeks US$11bn valuation in HK IPO
September 18 2017 by InsuranceAsia News-
Trade war fears ignite as Trump sweeps into the White House
- November 7
Even if heavy tariffs are not swiftly imposed, the threat of them is likely to make Chinese-US relations a lot more uncertain in the coming years and could hamper China’s economic recovery even further.
-
Seoul Guarantee Insurance’s H1 loss ratios worsen as claims surge: report
- October 8
Total claims paid out in the first six months reached nearly US$400m, an all-time high, and is expected to nearly double by the end of 2024.
-
Indian regulator urges insurers to go public: report
- October 7
In its meetings with senior insurance officials, IRDAI is nudging companies that have been in operation for more than a decade to list in a bid to align with global corporate governance standards.
-
Indian government launches US$560m sale of 6.8% GIC Re stake
- September 4
The secondary placement, being offered at a floor price of US$4.70 apiece over two days, is intended to reduce the government's stake in the reinsurer to meet the minimum public float requirements for Indian listed companies.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
